MS
GILD icon

Marshall & Sullivan’s Gilead Sciences GILD Stock Holding History

Marshall & Sullivan’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-26,179
Closed -$1.64M – 43
2018
Q4 		$1.64M Buy
26,179
+58
+0.2% +$4.05K 1.42% 25
2018
Q3 		$2.02M Buy
26,121
+1,340
+5% +$101K 1.47% 26
2018
Q2 		$1.76M Buy
24,781
+1,481
+6% +$105K 1.62% 24
2018
Q1 		$1.76M Buy
23,300
+661
+3% +$52.5K 1.43% 26
2017
Q4 		$1.62M Buy
22,639
+317
+1% +$24.1K 1.3% 27
2017
Q3 		$1.67M Buy
22,322
+860
+4% +$65.8K 1.55% 25
2017
Q2 		$1.52M Buy
21,462
+125
+0.6% +$8.32K 1.31% 27
2017
Q1 		$1.41M Buy
21,337
+2,255
+12% +$159K 1.22% 27
2016
Q4 		$1.37M Buy
19,082
+662
+4% +$49.2K 1.66% 25
2016
Q3 		$1.46M Buy
18,420
+537
+3% +$43.6K 1.87% 24
2016
Q2 		$1.49M Sell
17,883
-24
-0.1% -$2.13K 1.92% 25
2016
Q1 		$1.65M Buy
17,907
+620
+4% +$55.9K 2.09% 24
2015
Q4 		$1.75M Buy
17,287
+50
+0.3% +$5.2K 2.31% 24
2015
Q3 		$1.85M Buy
17,237
+43
+0.3% +$4.78K 2.41% 23
2015
Q2 		$2.01M Buy
17,194
+94
+0.5% +$10.3K 2.71% 21
2015
Q1 		$1.68M Sell
17,100
-252
-1% -$25.6K 2.16% 26
2014
Q4 		$1.64M Sell
17,352
-1,055
-6% -$109K 2.03% 27
2014
Q3 		$1.96M Buy
18,407
+2,936
+19% +$287K 2.75% 21
2014
Q2 		$1.28M Sell
15,471
-651
-4% -$50.7K 2.14% 25
2014
Q1 		$1.14M Sell
16,122
-26
-0.2% -$2.04K 2.06% 24
2013
Q4 		$1.21M Buy
16,148
+189
+1% +$13.2K 2.23% 25
2013
Q3 		$1M Sell
15,959
-35
-0.2% -$2.09K 1.88% 26
2013
Q2 		$820K Buy
+15,994
New +$834K 1.66% 28

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Marshall & Sullivan's GILD Position: Q1 2019 in Review

Marshall & Sullivan sold out of Gilead Sciences (GILD) in Q1 2019, closing a stake of 26,179 shares — an estimated $1.64M sold.

Marshall & Sullivan first reported a position in GILD in Q2 2013 and held it in 23 quarters. The position peaked at $2.02M in Q3 2018. 1,492 funds tracked by Wall St. Rank hold GILD as of Q1 2019.

  • Marshall & Sullivan reported no remaining Gilead Sciences position as of Q1 2019 after selling out during the quarter.
  • Marshall & Sullivan sold 26,179 Gilead Sciences shares in Q1 2019, an estimated $1.64M.
  • Marshall & Sullivan first reported a position in Gilead Sciences in Q2 2013 and held it in 23 quarters.
  • Marshall & Sullivan's Gilead Sciences position peaked at $2.02M in Q3 2018.
  • 1,492 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2019.

Based on Marshall & Sullivan's 13F filing for Q1 2019, filed 8 May 2019.